Action Alert

Tell California Legislators We Can't Afford to Jeopardize Patient Access & Biotech Investment

The California Assembly is currently considering SB 17, a bill that would jeopardize patient access to critical innovative medications, while doing nothing to address the price consumers actually pay for their medicines. It would also put investments in California's innovative biotech companies at risk, harming our economy.

This bill is unfeasible and misguided. Instead of addressing the price that California consumers actually pay for health care, it will drain investment in new medicines and make it more difficult to deliver breakthrough therapies to patients.

Send a message to your legislators and tell them to reject SB 17 so that we can focus on the real cost drivers of life-saving medications and tell the whole story about the cost of medicine.
Recipients
    Guidelines
    Message
    Remaining: 0
    Message
    Remaining: 0
    Suggested Message
    Message
    Remaining: 0
  • Hide
    • Phone Number
      Please call this number:
      Phone Script
      Response Report

      Your code has been sent!

      Please do not close this window. Minimize the window instead. You will need to come back to this window to enter your code.

      We have sent an email to ... with a verification code. If you do not see it within the next five minutes, please check your spam/junk mail folder.


      If you did not receive your verification email, click cancel and check that you entered your email address correctly.

      Enter Your Info
      Your Information
      Home Information
      Business Information

      Enter Your Info